Clinical Trials Directory

Trials / Completed

CompletedNCT07026448

Radicle Energy™: A Study Assessing the Impact of Health and Wellness Products on Fatigue

Radicle Energy™ 24_OS: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Health Outcomes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,000 (actual)
Sponsor
Radicle Science · Industry
Sex
All
Age
21 Years – 105 Years
Healthy volunteers
Accepted

Summary

A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on fatigue and related health outcomes

Detailed description

This is a randomized, double-blind, placebo-controlled study conducted with adult participants, residing in the United States. Eligible participants will (1) have the opportunity for meaningful improvement (at least 30%) in their primary health outcome, and (2) express acceptance in taking a product and not knowing its formulation until the end of the study. Participants that report a known cardiac dysfunction, liver or kidney disease may be excluded. Participants that report a known contraindication or with well-established, significant safety concerns due to illness will be excluded. Heavy drinkers and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Participants that report taking medications with a known contraindication or with well-established, significant safety concerns will be excluded. Self-reported data are collected electronically from eligible participants for 7 weeks. Participant reports of health indicators will be collected at baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEnergy Placebo ControlParticipants will use their Energy Placebo Control as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTEnergy Active Product 1Participants will use their Energy Active Product 1 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTEnergy Active Product 2Participants will use their Energy Active Product 2 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTEnergy Active Product 3Participants will use their Energy Active Product 3 as directed for a period of 6 weeks.

Timeline

Start date
2025-06-17
Primary completion
2025-09-21
Completion
2025-09-21
First posted
2025-06-18
Last updated
2025-10-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07026448. Inclusion in this directory is not an endorsement.